Firmament-Backed Panacea Acquires KA Consulting, Expanding Eligibility Determination and Revenue Integrity Capabilities
KADelisted Stock | 0.48 0.04 7.69% |
About 59% of Kineta's investor base is looking to short. The analysis of current outlook of investing in Kineta Inc suggests that many traders are alarmed regarding Kineta's prospects. The current market sentiment, together with Kineta's historical and current headlines, can help investors time the market. In addition, many technical investors use Kineta Inc stock news signals to limit their universe of possible portfolio assets.
Kineta |
PRNewswire -- Firmament-backed Panacea Healthcare Solutions , a leading provider of healthcare financial and clinical software and...
Read at prnewswire.com
Kineta Fundamental Analysis
We analyze Kineta's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kineta using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kineta based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Kineta is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Kineta Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Kineta stock to make a market-neutral strategy. Peer analysis of Kineta could also be used in its relative valuation, which is a method of valuing Kineta by comparing valuation metrics with similar companies.
Peers
Kineta Related Equities
ALVR | Allovir | 10.76 | ||||
FBRX | Forte Biosciences | 8.78 | ||||
CADL | Candel Therapeutics | 3.95 | ||||
MLYS | Mineralys Therapeutics, | 3.24 | ||||
TPST | Tempest Therapeutics | 1.14 | ||||
RZLT | Rezolute | 0.83 | ||||
ANTX | AN2 Therapeutics | 0.79 | ||||
MOLN | Molecular Partners | 0.57 | ||||
XOMAO | XOMA | 0.48 | ||||
PTIX | Protagenic Therapeutics | 0.37 | ||||
PEPG | PepGen | 1.01 | ||||
DYAI | Dyadic International | 1.28 | ||||
DMAC | DiaMedica Therapeutics | 1.66 | ||||
PHVS | Pharvaris | 2.41 | ||||
SILO | Silo Pharma | 3.61 | ||||
INKT | Mink Therapeutics | 3.96 | ||||
ANEB | Anebulo Pharmaceuticals | 8.07 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Kineta Stock
If you are still planning to invest in Kineta Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kineta's history and understand the potential risks before investing.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |